Marginal prescription equivalent to the isocenter prescription in lung stereotactic body radiotherapy: preliminary study for Japan Clinical Oncology Group trial (JCOG1408)

A new randomized Phase III trial, the Japan Clinical Oncology Group (JCOG) 1408, which compares two dose fractionations (JCOG 0403 and JCOG 0702) for medically inoperable Stage IA NSCLC or small lung lesions clinically diagnosed as primary lung cancer, involves the introduction of a prescribed dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawahara, Daisuke, Ozawa, Shuichi, Kimura, Tomoki, Saito, Akito, Nishio, Teiji, Nakashima, Takeo, Ohno, Yoshimi, Murakami, Yuji, Nagata, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Regular Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321195/
https://www.ncbi.nlm.nih.gov/pubmed/28115532
http://dx.doi.org/10.1093/jrr/rrw096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321195/
https://www.ncbi.nlm.nih.gov/pubmed/28115532
http://dx.doi.org/10.1093/jrr/rrw096

Ejemplares similares